Member Info for larry10

Drb : " However, why not let the market know once you have done selling"

Because there is nothing to win ? And a notification costs 750€ to the AMF. Many funds find that way too much... Lol... Paperwork, nothing to win,nothing to loose, why Care...

"Vatel must have notified ncyt at some point, so where is the RNS?"
Or we Can suppose they asked for votes At agm and got some return implying they are no more here ? Or as they know those financing funds, that they take their money bck right away like habert and co. Spéculations of course.

Hillseeker : "Typos do happen, but this would have been immediately corrected. So, we can be pretty sure that Vatel's last Tuesday in date was March 2021."
Possible. If that's correct we wont see Big selling pressure early april, which would confirm what you Say.

"I don't think Biosynex will be stopping at 4%"
Me neither.
https://twitter.com/Larry64450205/status/1495322807814836225?t=mesKX1sQrBsfNwPRe_p1_w&s=19
That was thé chart the 11/02 and 14/02. They bought 1% in those two days. Look After and before, it's the same. From early february to today. SP is hold very tight while they're buying.
Wouldnt be surprised to have a tr1 on monday or tuesday telling 5,6 or 7%.
If theyre smart, we also could see a decrease on monday, would show they played with the spike from first rns to average down and get even more shares At a very good average. WS

B2, fyi, harbert and légal&général Never notified either.
(They too financed ncyt earlier)
So 1 imho.

Dont think imo either thats its important to ncyt. WS if they answer my mail.

PS : imo, dyor etcetc

Hi all, a few infos about Vatel.

In short : Vatel has no shares anymore, and that not since Yesterday but for some Time now. Exept the possible 1m blocked until march 2022 (if this info about the typo in the rns is realy true).

About the notifications of holdings :
What does an ii risk if they dont notify their holding ? Sword is right about this point : they risk to get their voting rights removed. They also risk a very Big penalty (lololol) from AMF : 18.000€

So if an ii's plan is to sell their position in a company, they dont give a f..K about this.

I thought Vatel was still here with all his shares. Having discussed that matter with a former ii Yesterday evening, spoke about Bloomberg which is still showing Vatel with his 4.18%, he told me not to rely on Bloomberg as it is not as accurate as i thought. He believes (rightfully imo) that Vatel sold asap his shares Were not blocked anymore. Explaining some Big sell offs we had on the bourse in january 2021 and some other dates coinciding with vatels blocked périodes.

So today, i dont think Vatel has many shares, maybe the one m still blocked (if true as previously said).

A Clue for the authenticity of my sayings :
https://novacyt.com/aim-rule-26/#aim-securities
Paragraph : Securities in issue :

-------------
Rule 17 of the AIM Rules requires, inter alia, that shareholders notify an AIM listed company once their holding is three per cent or more, and changes thereto (movements through a percentage point upwards or downwards).

Significant shareholdings of 3% or more at 18 February 2022 were as follows:

Biosynex SA – 2,855,959 shares (4.04%)
--------------

So Vatel doesnt appear anymore on that paragraph. I remember seeing him some Time in 2021 (a long Time ago, not end of 2021) though.
So from ncyts point of view, they (Vatel) are no longer significant shareholders. IE above 3%.

A Big question is, why no rns announcing the downward crossing of the 4 and then 3% ?
Easy, as told above, Vatel didnt gave a SH.t about notifiyng the company as they have nothing to loose exept their voting rights - doesnt Care as they sold - and this little fine if the company or someone else file a complaint against them.

For clarity, i sended a mail to IR Yesterday, to see what they answer.

So another point is Vatel couldnt sold his shares to biosynex as they are no longer shareholders - surely as soon as they could sell.
I still believe biosynex bought in on the market.

Hope it helps.

Can we go back to a far more interesting subject that is WHY are they buying ?

Takeover ? Do they have enough financial power ?

Partnership ? Merger ? Distribution agreement ? Trading the stock ?
What kinds ? why ? why buy shares ?/to achieve this ?

Is the ncyt BoD aware of the why ? Do they see this as positive or the contrary ?

Starbright, i was more thinking regulations from a french side as it's a domain i know better, and ncyt seems to follow many french rules. I'll try to get a confirmation from IR and will share it.

Babyhuey, the following sentence has been confirmed by IR a while ago, one or two Years ago now, that the year was wrong and is 2022 and not 2021 : " 1,033,438 Ordinary Shares will not be sold or transferred before 31 March 2021."

Sword20, starting to p*issing me off tbh. Vatel has still 1% blocked, so only 3% avaiable = your theory doesnt work.
2/ if you can't look closer, i can't do anything for you.if you dont know how ii's (and co's) do to buy in while keeping SP low, ...
Looking close At the chart and having discussed this matter with a number of holders, its more likely that they bought since early february.

I dont pretend to know everything, i know ive made more than one error, mais en tout cas tu es imbuvable comme type !

I will not directly answer to your question. But yes there are some Legal obligations that everyone has to follow.

I will answer in another way, why its not Vatel selling.
1/ why would have the transaction not been done all At once ? Why 3 and two days mater 4% ?
2/ look the chart, look the order book, to me it's obvious they buy on market.
3/ as some remembered, Vatel has 4.18% but some are still blocked and not to sell. So how does biosynex buys 4.04% from them ? Not possible.

Would like to stop speaking about this, i dont see it as important.

Why are there buying is imo more interesting, no ?

Quoting Ysb41 :
"as at 10 February 2022, Biosynex's holding in the Company on a voting and capital basis is 3.0012% (2,119,627 shares).
as at 14 February 2022, Biosynex's holding in the Company on a voting and capital basis is 4.04% (2,855,959 shares).

Volume
Feb 17, 2022 497,616
Feb 16, 2022 1,441,526
Feb 15, 2022 1,846,711

Feb 14, 2022 272,058
Feb 11, 2022 356,476
Feb 10, 2022 588,709"

https://twitter.com/Larry64450205/status/1494726754627461120?t=x7OQ4eAu4ZNTUxIrpc-9Aw&s=19
Here the volume of the past days in picture.

So with an exteemly low volume the 11/02 and 14/02 (weekend in between), biosynex managed to buy another 1% or circa 700ks

With 2.8m shares traded since then, i guess monday will have another TR1 with the crossing of 5% if not 6%. 7% would be surprising.

Whats their goal ? Imo
- target is 10 or 20% like theradiag.
- some commercial agreement. Distribution, R&D, anyway some partnership.
- Takeover is unlikely for me, i don't see enough money power to buy us.

And to finish, a off book buying by biosynex is highly highly unlikely. Looking At the order book and chart this week, it's pretty obvious to me they bought on Euronext on the market. Any allegations that another ii like Vatel sold shares to them is imo wrong, as the shares are imo bought on open market and no tr1 from Vatel showing a decrease in holding. Would be illégal not to declare it and subject to penalties by AMF.

Nonsense

Ok it's confirmed you dont know much. I will listen to Kaerens advice from now on.

"Any natural or legal person, acting alone or collectively, who directly or indirectly
comes into possession of a number of Shares equal to 3 per cent. of the entire
issued share capital of the Company and subsequently every 1 per cent. increase or
decrease, must supply the Company with the information mentioned in article L.233-7
I of the French Commercial Code (including number of Shares and voting rights held
by the relevant Shareholder) by means of a registered letter with acknowledgment of
receipt, within a period of four stock market trading days as from the date on which
the above-mentioned threshold was exceeded. Should any of the Shareholders fail to
comply with these obligations, the Company shall be entitled (having received a
request from any Shareholder holding an amount equal to or greater than 5 per cent.
of the entire issued share capital of the Company) to remove all voting rights
attaching to the Shares of the defaulting Shareholder for which any such disclosure
was required but not provided, for a period of two years commencing from the date
the requisite disclosure should have been provided."

http://novacyt.com/wp-content/uploads/2017/10/Admission-Document-Novacyt-18-October-2017.pdf

Page 138. You're welcome.

Its not done off book, its pretty obvious orders being filled on Euronext. Just watch the chart.
Whos selling ? Traders, pi's, little funds maybe !

Exept he has 2.952.681 shares = 4.18%

If he had sold and he was under 4% it would have been rnsd.

If vatels position had moved, it would have been rnsd. Treshold At 4% and 3%. They have 4.18% atm, so any little sell would trigger a rns.

https://m.zonebourse.com/cours/action/BIOSYNEX-7449168/societe/

54% owned by BoD and company

https://www.morningstar.com/stocks/xpar/albio/ownership

And here some ii's

40% of biosynex is privately owned by the co (or the boss ceo can't remember but something like that). Several BoD members have also bought shares this or past week

Agree captainswag, imo theyre not trading. Imo something like with theradiag coming/ is their goal. And imo they've kept buying all week. WS next week if tr1

You might need to read biosynex History.
They bought 20% of theradiag and signed a distribution agreement a month later.

They took 20% from theradiag without doing a buyout.

But they signed a distribution partnership a few weeks later.

I think more of that yes.

An idea for example, ncyt may want have biosynexs LFT.
But here its biosynex taking shares. They might be interested in a partnership for instruments (Qs andor coprep) or the promate technology, or whatever else.

Biosynex wants to get more of the PoC testing sector they've said.

To be exact, page 138, why notify At 3% holding ? :

"Any natural or legal person, acting alone or collectively, who directly or indirectly
comes into possession of a number of Shares equal to 3 per cent. of the entire
issued share capital of the Company and subsequently every 1 per cent. increase or
decrease, must supply the Company with the information mentioned in article L.233-7
I of the French Commercial Code (including number of Shares and voting rights held
by the relevant Shareholder) by means of a registered letter with acknowledgment of
receipt, within a period of four stock market trading days as from the date on which
the above-mentioned threshold was exceeded. Should any of the Shareholders fail to
comply with these obligations, the Company shall be entitled (having received a
request from any Shareholder holding an amount equal to or greater than 5 per cent.
of the entire issued share capital of the Company) to remove all voting rights
attaching to the Shares of the defaulting Shareholder for which any such disclosure
was required but not provided, for a period of two years commencing from the date
the requisite disclosure should have been provided."

http://novacyt.com/wp-content/uploads/2017/10/Admission-Document-Novacyt-18-October-2017.pdf